NasdaqGS - Nasdaq Real Time Price ? USD CeriBell, Inc. (CBLL) Follow Compare 26.28 -0.15 (-0.57%) At close: October 25 at 4:00 PM EDT 25.78 -0.50 (-1.90%) After hours: October 25 at 4:32 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG Ceribell, Inc. (Nasdaq: CBLL), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced the presentation of data in five abstracts at the 2024 Neurocritical Care Society (NCS) Annual Meeting being held from October 14-17 in San Diego. The analyses—which include 937 point-of-care EEG cases and recordings—add to the growing body of evidence highlighting the potential of Ceribell's point-of-c PR Newswire ? 9 days ago CBLL -0.57% CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, announced today the closing of its upsized initial public offering of 12,196,969 shares of its common stock at a public offering price of $17.00 per share, which includes 1,590,909 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares. The PR Newswire ? 10 days ago CBLL -0.57% Opening Day: Another trio of biotech IPOs make Friday debut The Partners Group-backed KinderCare sold 24 million shares for $24 each this Tuesday. At the IPO price, the childhood education company had a market value of $2.74B, based on the outstanding shares. Sky Quarry, Click Holdings, and SKK Holdings also opened for trading this week. Meanwhile, a new trio of biotech companies’ shares came to market on Friday as Upstream Bio, Ceribell and Camp4 Therapeutics each made their public debut. In mid-September, Bicara Therapeutics (BCAX), MBX Biosciences (MB TipRanks ? 11 days ago C CBLL -0.57% ZBIO -12.78% CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs (Bloomberg) -- Three US life-sciences companies hitting the market delivered mostly robust early trading after investors strongly supported their initial public offerings.Most Read from BloombergDubai’s Allure to Expats Is Weighing on City’s InfrastructureThe Master Plan That Shaped Pakistan’s Capital Is No Longer WorkingThe Cablebus Transformed Commutes in Mexico City’s Populous OutskirtsAs Brussels Booms, an Old Boogeyman Returns: BrusselizationChicago Marathon to Honor Kenyan Who Died After H Bloomberg ? 14 days ago CBLL -0.57% CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq The medtech startup, which operates an EEG platform that can detect seizures, had already priced shares above their expected range before they began trading. FastCompany ? 14 days ago CBLL -0.57% Upstream Bio Leads Life Sciences IPOs With Upsized Listing (Bloomberg) -- Three US life-sciences companies have so far exceeded or met their goals in initial public offerings Thursday, showing investor appetite for their capital-intensive businesses after a busy stretch of fundraising by peers.Most Read from BloombergThe Cablebus Transformed Commutes in Mexico City’s Populous OutskirtsSan Francisco to Shut 9% of Public Schools Amid Budget WoesAs Brussels Booms, an Old Boogeyman Returns: BrusselizationChicago Marathon to Honor Kenyan Who Died After His W Bloomberg ? 14 days ago CBLL -0.57% CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, announced today the pricing of its upsized initial public offering of 10,606,060 shares of its common stock at a public offering price of $17.00 per share. In connection with the offering, Ceribell has granted the underwriters a 30-day option to purchase up to an additional 1,590,909 shares of common stock PR Newswire ? 15 days ago CBLL -0.57% Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return CBLL S&P 500 YTD +12.98% -0.12% 1-Year +12.98% -0.12% 3-Year +12.98% -0.12%
